The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population.

Molecular biology reports

Volumn 39, Issue 12, 2012, Pages 11017-11022

  Silan, Coskun ^a   Dogan, Omer Tamer ^b   Silan, Fatma ^b   Kukulguven, Fatma Mutlu ^b   Asgun, Halil Fatih ^b   Ozdemir, Semra ^b   Uludag, Ahmet ^b   Atik, Sinem ^b   Gungor, Buket ^b   Akdur, Seçil ^b   Aksulu, Hakki Engin ^b   Ozdemir, Oztürk ^b  

^a ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CYP2C9 PROTEIN, HUMAN; MENADIONE EPOXIDASE; MIXED FUNCTION OXIDASE; UNSPECIFIC MONOOXYGENASE;

ADULT; AGED; ALLELE; ARTICLE; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTICOAGULANTS; ARYL HYDROCARBON HYDROXYLASES; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; TURKEY;

EID: 85027958881     PISSN: None     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2004-2     Document Type: Article

References (0)